deltatrials

AO Clinical Investigation and Publishing Documentation Clinical Trials

Sponsors / AO Clinical Investigation and Publishing Documentation

According to ClinicalTrials.gov, AO Clinical Investigation and Publishing Documentation has served as lead sponsor on 51 registered trials. Across the portfolio, 0 are in recruitment, 2 are active non-recruiting, and 41 have reached completion. 8 trials have been terminated or withdrawn. The most common reasons cited for termination include efficacy or futility findings, slow or insufficient recruitment. Across the portfolio, planned enrollment totals 10,769 participants. Data on this page mirrors the ClinicalTrials.gov registry as of the most recent refresh.

51
Total Trials
0
Recruiting
2
Other Active
41
Completed
8
Terminated / Withdrawn
10,769
Total Enrollment

Termination reasons: Other38% · Efficacy25% · Recruitment25% · Funding13%

Recent Terminations

  • NCT03849898 Stopped Mar 2023
    Mandibular Fractures
    "Low recruitment"
  • NCT03380273 Phase NA Stopped Dec 2021
    Surgical Site Infection
    "Patient enrollment too small and slow due to pandemic situation"
  • NCT02096146 Phase NA Stopped Aug 2016
    Clinical Indication for First Metatarsal Joint Arthrodesis
    "Lack of enrolment"
  • NCT01751633 Stopped Dec 2015
    Multiple Level Stable Thoracolumbar Fracture Type AO A3
    "Administrative reason. Lack of funding."
  • NCT01079637 Phase NA Stopped May 2013
    Diabetes Mellitus 1 or 2
    "The study was stopped because there were not enough eligible patients to complete the study."
  • NCT00822159 Phase NA Stopped Sep 2011
    Bone Density
    "Interim analysis showed statistically significant results"
  • NCT00206037 Phase PHASE4 Stopped Feb 2007
    High Tibia Osteotomy
    "Interim analysis showed significant results, thus study was stopped"
  • NCT00205998 Phase PHASE4 Stopped Dec 2005
    Distal Radius Fractures
    "Study completed"

Active Trials (2 total)

Top Conditions

Top Locations